Clinical Litigation Services is categorized under Services (Unclassified) in Anaheim, CA and active since 2011.
Clinical Litigation Services was established in 2011, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Services (Unclassified) business, which does work in the B2B market, and is classified as a Services (Unclassified), under code number 541990 by the NAICS.
If you are seeking more information, feel free to contact Tina Sorenson at the company’s single location by writing to 8745 East Wiley Way, Anaheim, California CA 92808 or by phoning (714) 342-7260. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Clinical Litigation Services |
| Contact Person: | Tina Sorenson |
| Address: | 8745 East Wiley Way, Anaheim, California 92808 |
| Phone Number: | (714) 342-7260 |
| Annual Revenue (USD): | $50.000 to $99.999 |
| Founded: | 2011 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Services (Unclassified) |
| SIC Code: | 8999 |
| NAICS Code: | 541990 |
| Share This Business: |
Clinical Litigation Services was started in 2011 to provide professional Services (Unclassified) under the SIC code 8999 and NAICS code 541990. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Tina Sorenson for inquiries that concern Clinical Litigation Services by calling the company number (714) 342-7260, as your correspondence is most welcome. Additionally, the physical location of the single location of Clinical Litigation Services can be found at the coordinates 33.855646,-117.72443 as well as the street address 8745 East Wiley Way in Anaheim, California 92808.
For its online presence, you may visit Clinical Litigation Services’s website at and engage with its social media outlets through on Twitter and on Facebook.